BPTH - Bio-Path Holdings, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.79
0.00 (0.00%)
As of 9:39AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.79
Open1.79
Bid1.70 x 1000
Ask1.93 x 1900
Day's Range1.79 - 1.79
52 Week Range1.54 - 7.30
Volume3,188
Avg. Volume348,353
Market Cap20.3M
Beta2.22
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Bio-Path Leukemia Combo Study Shows Positive Early Data
    Zacks20 days ago

    Bio-Path Leukemia Combo Study Shows Positive Early Data

    Bio-Path (BPTH) announces positive interim data from phase II study of its lead pipeline candidate ??? prexigebersen ??? in combination with low-dose cytarabine (LDAC) for leukemia patients.

  • Bio-Path: Why the Biotech Penny Stock Is Skyrocketing Today
    InvestorPlace21 days ago

    Bio-Path: Why the Biotech Penny Stock Is Skyrocketing Today

    The other bit of good news for BPTH stock today was financial results for its fiscal full year of 2017. During the year, the company reported a net loss of $8.1 million, or 80 cents per share. This is a wider net loss than the $6.8 million, or 73 cents per share from the year prior.

  • Benzinga21 days ago

    Benzinga Pro's 5 Stocks To Watch Today

    Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Long Blockchain Corp (NASDAQ: LBCC ) stock gained ...

  • Bio-Path Holdings Inc (BPTH): How Does It Impact Your Portfolio?
    Simply Wall St.5 months ago

    Bio-Path Holdings Inc (BPTH): How Does It Impact Your Portfolio?

    If you are looking to invest in Bio-Path Holdings Inc’s (NASDAQ:BPTH), or currently own the stock, then you need to understand its beta in order to understand how it canRead More...

  • Associated Press5 months ago

    Bio-Path reports 3Q loss

    The Bellaire, Texas-based company said it had a loss of 2 cents per share. In the final minutes of trading on Thursday, the company's shares hit 30 cents. A year ago, they were trading at $1.21. _____ ...

  • Is It Time To Buy Bio-Path Holdings Inc (BPTH)?
    Simply Wall St.6 months ago

    Is It Time To Buy Bio-Path Holdings Inc (BPTH)?

    Bio-Path Holdings Inc (NASDAQ:BPTH), a pharmaceuticals company based in United States, received a lot of attention from a substantial price increase on the NasdaqCM in the over the last fewRead More...

  • Associated Press8 months ago

    Bio-Path reports 2Q loss

    The Bellaire, Texas-based company said it had a loss of 3 cents per share. The company's shares closed at 35 cents. A year ago, they were trading at $1.73. _____ This story was generated by Automated Insights ...

  • Associated Press11 months ago

    Bio-Path reports 1Q loss

    The Bellaire, Texas-based company said it had a loss of 1 cent per share. The company's shares closed at 59 cents. A year ago, they were trading at $2.75. _____ This story was generated by Automated Insights ...